SG Americas Securities, LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753U906. A total of 8 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$316
+15700.0%
145,000
+974.1%
0.00%
Q3 2023$2
-99.9%
13,500
-95.5%
0.00%
-100.0%
Q1 2023$2,190300,0000.02%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Twin Tree Management, LP 309,200$20,394,8320.04%
GROUP ONE TRADING, L.P. 109,900$7,249,0040.03%
SG Americas Securities, LLC 300,000$2,1900.02%
Worth Venture Partners, LLC 19,200$44,4800.02%
SIMPLEX TRADING, LLC 178,200$11,7540.01%
JANE STREET GROUP, LLC 259,200$17,096,8320.01%
JPMORGAN CHASE & CO 364,700$24,056,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of APELLIS PHARMACEUTICALS INC shareholders